Abstract:Abstract Migraine is a common chronic neurovascular disorder characterized by recurrent headache attacks that significantly impact patients' quality of life. Accumulating evidence indicates that neuroinflammation plays a critical role in the pathogenesis of migraine, with glial cell activation serving as a central component. Activated glial cells release pro-inflammatory mediators, contributing to neuronal injury. Recent studies have confirmed that abnormal activation of the NLRP3 inflammasome in glial cells within the trigeminal nucleus caudalis (TNC) is closely associated with central sensitization. Basic research has demonstrated that modulating autophagic flux can selectively clear core components and downstream molecules of the NLRP3 inflammasome (e.g., NLRP3, ASC, and pro-IL-1β), thereby effectively inhibiting the IL-1β-mediated neuroinflammatory cascade. However, emerging evidence suggests that impaired autophagic flux occurs in both migraine patients and animal models, which may represent a key mechanism underlying neuroinflammation and central sensitization in migraine. This review systematically summarizes recent advances in the understanding of the NLRP3/IL-1β signaling pathway in migraine, explores the potential pathogenic role of autophagy dysfunction in its pathophysiology, and proposes, for the first time, a positive feedback loop involving “autophagy dysfunction–neuroinflammation–central sensitization.” The aim is to provide new directions for future research and targeted therapeutic strategies in this field.